Company financials and filings can be accessed at the links below.

Innovation Pharmaceuticals (sec.gov)

Latest Filings

December 5, 2023 - 8-K: Current report

November 20, 2023 - 10-Q: Quarterly report for quarter ending September 30, 2023

October 30, 2023 - 8-K: Current report

September 28, 2023 - 10-K: Annual report for year ending June 30, 2023

May 15, 2023 - 10-Q: Quarterly report for quarter ending March 31, 2023

February 15, 2023 - 10-Q: Quarterly report for quarter ending December 31, 2022

November 10, 2022 - 10-Q: Quarterly report for quarter ending September 30, 2022

September 28, 2022 - 10-K: Annual report for year ending June 30, 2022

June 15, 2022 - 8-K: Current report

May 13, 2022 - 10-Q: Quarterly report for quarter ending March 31, 2022

February 14, 2022 - 10-Q: Quarterly report for quarter ending December 31, 2021

November 9, 2021 - 10-Q: Quarterly report for quarter ending September 30, 2021

October 14, 2021 - 8-K: Current report

September 27, 2021 - 10-K: Annual year for year ending June 30, 2021

May 13, 2021 - 10-Q: Quarterly report for quarter ending March 31, 2021

May 3, 2021 - SC 13G/A: Statement of acquisition of beneficial ownership by individuals - amendment

February 22, 2021 - 10-Q: Quarterly report for quarter ending December 31, 2020